Searched for: in-biosketch:true
person:jainr04
Cell surface Notch ligand DLL3 is a therapeutic target in isocitrate dehydrogenase mutant glioma
Spino, Marissa; Kurz, Sylvia C; Chiriboga, Luis; Serrano, Jonathan; Zeck, Briana; Sen, Namita; Patel, Seema; Shen, Guomiao; Vasudevaraja, Varshini; Tsirigos, Aristotelis; Suryadevara, Carter M; Frenster, Joshua D; Tateishi, Kensuke; Wakimoto, Hiroaki; Jain, Rajan; Riina, Howard A; Nicolaides, Theodore; Sulman, Erik P; Cahill, Daniel P; Golfinos, John G; Isse, Kumiko; Saunders, Laura R; Zagzag, David; Placantonakis, Dimitris G; Snuderl, Matija; Chi, Andrew S
PURPOSE/OBJECTIVE:Isocitrate dehydrogenase (IDH) mutant gliomas are a distinct glioma molecular subtype for which no effective molecularly-directed therapy exists. Low-grade gliomas, which are 80-90% IDH mutant, have high RNA levels of the cell surface Notch ligand DLL3. We sought to determine DLL3 expression by immunohistochemistry in glioma molecular subtypes and the potential efficacy of an anti-DLL3 antibody drug conjugate (ADC), rovalpituzumab tesirine (Rova-T), in IDH mutant glioma. EXPERIMENTAL DESIGN/METHODS:We evaluated DLL3 expression by RNA using TCGA data and by immunohistochemistry in a discovery set of 63 gliomas and 20 non-tumor brain tissues and a validation set of 62 known IDH wildtype and mutant gliomas using a monoclonal anti-DLL3 antibody. Genotype was determined using a DNA methylation array classifier or by sequencing. The effect of Rova-T on patient-derived endogenous IDH mutant glioma tumorspheres was determined by cell viability assay. RESULTS:Compared to IDH wildtype glioblastoma, IDH mutant gliomas have significantly higher DLL3 RNA (P<1x10-15) and protein by immunohistochemistry (P=0.0014 and P<4.3x10-6 in the discovery and validation set, respectively). DLL3 immunostaining was intense and homogeneous in IDH mutant gliomas, retained in all recurrent tumors, and detected in only 1 of 20 non-tumor brains. Patient-derived IDH mutant glioma tumorspheres overexpressed DLL3 and were potently sensitive to Rova-T in an antigen-dependent manner. CONCLUSIONS:DLL3 is selectively and homogeneously expressed in IDH mutant gliomas and can be targeted with Rova-T in patient-derived IDH mutant glioma tumorspheres. Our findings are potentially immediately translatable and have implications for therapeutic strategies that exploit cell surface tumor-associated antigens.
PMID: 30397180
ISSN: 1078-0432
CID: 3455762
State of the Art: Machine Learning Applications in Glioma Imaging
Lotan, Eyal; Jain, Rajan; Razavian, Narges; Fatterpekar, Girish M; Lui, Yvonne W
OBJECTIVE:Machine learning has recently gained considerable attention because of promising results for a wide range of radiology applications. Here we review recent work using machine learning in brain tumor imaging, specifically segmentation and MRI radiomics of gliomas. CONCLUSION/CONCLUSIONS:We discuss available resources, state-of-the-art segmentation methods, and machine learning radiomics for glioma. We highlight the challenges of these techniques as well as the future potential in clinical diagnostics, prognostics, and decision making.
PMID: 30332296
ISSN: 1546-3141
CID: 3368562
High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma
Chapter by: Karajannis, Matthias A; Snuderl, Matija; Yeh, Brian K; Walsh, Michael F; Jain, Rajan; Sahasrabudhe, Nikhil A; Wisoff, Jeffrey H
in: Brain Tumors in Children by Gajjar, Amar; Reaman, Gregory H; Racadio, Judy M; Smith, Franklin O (Eds)
Cham : Springer, 2018
pp. 193-221
ISBN: 3319432052
CID: 3732452
Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in a Patient with Ataxia, Diplopia, and an Enhancing Cerebellar Lesion [Meeting Abstract]
Gutman, Josef; Fouladvand, Mohammad; Jafar, Jafar; Jain, Rajan; Kister, Ilya
ISI:000453090805156
ISSN: 0028-3878
CID: 3732432
Two novel mutations in CP associated with Aceruloplasminemia and basal ganglia cavitation [Meeting Abstract]
Riboldi, Giulietta Maria; Anstett, Kara; Jain, Rajan; Lau, Heather; Swope, David
ISI:000453090804319
ISSN: 0028-3878
CID: 3561742
How Far Are We from Using Radiomics Assessment of Gliomas in Clinical Practice?
Jain, Rajan; Lui, Yvonne W
PMID: 30277444
ISSN: 1527-1315
CID: 3329202
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas
Wu, C-C; Jain, R; Radmanesh, A; Poisson, L M; Guo, W-Y; Zagzag, D; Snuderl, M; Placantonakis, D G; Golfinos, J; Chi, A S
BACKGROUND AND PURPOSE/OBJECTIVE:Few studies have shown MR imaging features and ADC correlating with molecular markers and survival in patients with glioma. Our purpose was to correlate MR imaging features and ADC with molecular subtyping and survival in adult diffuse gliomas. MATERIALS AND METHODS/METHODS:promoter methylation, and overall survival. RESULTS:wild-type glioma. Other MR imaging features were not statistically significant predictors of survival. CONCLUSIONS:wild-type gliomas.
PMID: 30190259
ISSN: 1936-959x
CID: 3271772
Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas
Chang, P; Grinband, J; Weinberg, B D; Bardis, M; Khy, M; Cadena, G; Su, M-Y; Cha, S; Filippi, C G; Bota, D; Baldi, P; Poisson, L M; Jain, R; Chow, D
BACKGROUND AND PURPOSE/OBJECTIVE:The World Health Organization has recently placed new emphasis on the integration of genetic information for gliomas. While tissue sampling remains the criterion standard, noninvasive imaging techniques may provide complimentary insight into clinically relevant genetic mutations. Our aim was to train a convolutional neural network to independently predict underlying molecular genetic mutation status in gliomas with high accuracy and identify the most predictive imaging features for each mutation. MATERIALS AND METHODS/METHODS:) promotor methylation status. Principal component analysis of the final convolutional neural network layer was used to extract the key imaging features critical for successful classification. RESULTS:promotor methylation status, 83%. Each genetic category was also associated with distinctive imaging features such as definition of tumor margins, T1 and FLAIR suppression, extent of edema, extent of necrosis, and textural features. CONCLUSIONS:Our results indicate that for The Cancer Imaging Archives dataset, machine-learning approaches allow classification of individual genetic mutations of both low- and high-grade gliomas. We show that relevant MR imaging features acquired from an added dimensionality-reduction technique demonstrate that neural networks are capable of learning key imaging components without prior feature selection or human-directed training.
PMID: 29748206
ISSN: 1936-959x
CID: 3196432
Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study
Maldonado, M D; Batchala, P; Ornan, D; Fadul, C; Schiff, D; Itri, J N; Jain, R; Patel, S H
PURPOSE/OBJECTIVE:The neuroimaging diagnosis of diffuse gliomas can be challenging owing to their variable clinical and radiologic presentation. The purpose of this study was to identify factors that are associated with imaging errors in the diagnosis of diffuse gliomas. METHODS:A retrospective case-control analysis was undertaken. 18 misdiagnosed diffuse gliomas on initial neuroimaging (cases) and 108 accurately diagnosed diffuse gliomas on initial neuroimaging (controls) were collected. Clinical, pathological, and imaging metrics were tabulated for each patient. The tabulated metrics were compared between cases and controls to determine factors associated with misdiagnosis. RESULTS:Cases of misdiagnosed diffuse glioma (vs controls) were more likely to undergo initial triage as a stroke workup [OR 14.429 (95% CI 4.345, 47.915), p < 0.0001], were less likely to enhance [OR 0.283 (95% CI 0.098, 0.812), p = 0.02], were smaller (mean diameter 4.4 vs 6.0 cm, p = 0.0008), produced less midline shift (median midline shift 0.0 vs 2.0 mm, p = 0.003), were less likely to demonstrate necrosis [OR 0.156 (95% CI 0.034-0.713), p = 0.008], and were less likely to have IV contrast administered on the initial MRI [OR 0.100 (95% CI 0.020, 0.494), p = 0.008]. CONCLUSION/CONCLUSIONS:Several clinical and radiologic metrics are associated with diffuse gliomas that are missed or misdiagnosed on the initial neuroimaging study. Knowledge of these associations may aid in avoiding misinterpretation and accurately diagnosing such cases in clinical practice.
PMID: 29959694
ISSN: 1573-7373
CID: 3163072
Aceruloplasminemia and putaminal cavitation [Letter]
Riboldi, Giulietta Maria; Anstett, Kara; Jain, Rajan; Lau, Heather; Swope, David
PMID: 29534945
ISSN: 1873-5126
CID: 3157492